Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001999921 | SCV002235483 | pathogenic | not provided | 2021-12-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn83Lysfs*9) in the HPS3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPS3 are known to be pathogenic (PMID: 11590544). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with HPS3-related conditions. This variant is present in population databases (rs770108122, gnomAD 0.004%). |
Baylor Genetics | RCV003471135 | SCV004192318 | likely pathogenic | Hermansky-Pudlak syndrome 3 | 2022-09-27 | criteria provided, single submitter | clinical testing |